MALVERN, Pa., Aug. 09, 2023 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to…Original Article
Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese
